Kirsten Bell Burdett

7PUBLICATIONS
52CO-AUTHORS
NanomedicineSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2025
Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.

Karl J Habashy, Timothy W Synold, Ye Feng

|Dec 16, 2024
Association of Neighborhood-Level Area Deprivation with Demographics and Outcomes in Oropharyngeal Squamous Cell Carcinoma.

Shravan Asthana, Asher C Park, Abhinav Talwar

|Jan 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma.

Karl J Habashy, Crismita Dmello, Li Chen

|Nov 08, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.

Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett

|Nov 18, 2022
Determining venous thromboembolism risk in patients with adult-type diffuse glioma.

Kirsten Bell Burdett, Dusten Unruh, Michael Drumm

|Aug 05, 2020
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.

Yingmiao Liu, Jing Lyu, Kirsten Bell Burdett

Pageof 2

Frequent Collaborators

3 joint publications

Víctor A Arrieta

3 joint publications

Roger Stupp

3 joint publications

Karl J Habashy

3 joint publications

Adam M Sonabend